Patent directory · USPTO A61K / A61P
Patents matching “The United States of America as represented by the Secretary of the Army”
225 pharma patents match "The United States of America as represented by the Secretary of the Army" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 225 pharmaceutical patents matching "The United States of America as represented by the Secretary of the Army" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7825154
Small molecule inhibitors of botulinum neurotoxins
granted -
US 7790186
Plasmodium vivax hybrid circumsporozoite protein and vaccine
granted -
US 7790182
Protein vaccines against poxviruses
granted -
US 7790181
Live attenuated viral vaccines for Eastern Equine Encephalitis virus
granted -
US 7786285
Recombinant vaccine against botulinum neurotoxin
granted -
US 7780966
Artificial invaplex
granted -
US 7759106
Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli
granted -
US 7754461
Large-scale production of human serum butyrylcholinesterase as a bioscavenger
granted -
US 7741431
Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
granted -
US 7736656
Immunogenic compositions and vaccines for Ebola
granted -
US 7731975
Chimeric filovirus glycoprotein
granted -
US 7722889
Plasmodium liver stage antigens
granted -
US 7718779
Prophylactic and therapeutic monoclonal antibodies
granted -
US 7682618
Generation of virus-like particles and use as panfilovirus vaccine
granted -
US 7678828
Methods for the formulation and manufacture of artesunic acid for injection
granted -
US 7666404
Glanders/meliodosis vaccines
granted -
US 7662568
Immunoliposome-nucleic acid amplification (ILNAA) assay
granted -
US 7638333
Anthrax vaccine
granted -
US 7632659
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
granted -
US 7625571
Transformed bacteria producing CS6 antigens as vaccines
granted -
US 7604811
Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
granted -
US 7595191
Isolation and purification of P. falciparum merozoite protein-142 vaccine
granted -
US 7582430
Immunoliposome-nucleic acid amplification (ILNAA) assay
granted -
US 7582680
Methods and compositions for treating mammalian spinal cord injuries
granted